marginally significantP-value = 0.085
In the model adjusting for both the primary IgA and primary IgG V1V2 readouts, vaccine recipients with positive 92TH023-V1V2-specific complement activating antibodies had a significantly lower infection risk than vaccine recipients with negative response (OR = 0.42, P-value = 0.048, Table 3 ), and a similar marginally significant result was found for A244-V1V2 (OR = 0.49, P-value = 0.085, Table 3 ).